| P50 | author | Zongjin Li | Q38544295 |
| | Zhongliang Wang | Q81412775 |
| P2093 | author name string | Chen Shen | |
| | Yang Du | |
| | Jie Tian | |
| | Dong Peng | |
| | Xiao-Hua Jia | |
| | Hui Hui | |
| | De-Ling Kong | |
| | Guo-Wei Feng | |
| P2860 | cites work | Mesenchymal stem cells: immune evasive, not immune privileged | Q27003371 |
| | Immunobiology of mesenchymal stem cells | Q27004487 |
| | Immunity, Inflammation, and Cancer | Q27861048 |
| | Mesenchymal stem cells in health and disease | Q29614296 |
| | Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 |
| | Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 |
| | Protective and pathogenic functions of macrophage subsets | Q29620351 |
| | Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 |
| | In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging | Q30407270 |
| | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype | Q33570359 |
| | Mesenchymal stem cell signaling in cancer progression | Q34267450 |
| | Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis | Q34429538 |
| | Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth | Q34457728 |
| | FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells | Q34619436 |
| | Hypoxia and the extracellular matrix: drivers of tumour metastasis | Q34820282 |
| | Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms | Q35024882 |
| | Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. | Q35112231 |
| | Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation | Q35665181 |
| | CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα | Q36456715 |
| | Toll-like receptors and cancer | Q37340298 |
| | The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine | Q37720654 |
| | Multipotent mesenchymal stromal cells and the innate immune system | Q38005275 |
| | Mesenchymal stromal cells: new directions. | Q38019173 |
| | Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 |
| | Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications | Q38261365 |
| | Immunology. Making macrophages eat cancer | Q43884851 |
| | A multilevel adaptive finite element algorithm for bioluminescence tomography. | Q51934172 |
| | Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. | Q53390457 |
| | Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| | tumor progression | Q16909647 |
| P304 | page(s) | 20934-20944 | |
| P577 | publication date | 2016-03-14 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects | |
| P478 | volume | 7 | |